A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)

NCT02241772 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Elevated Lp(a)

Interventions

DRUG: TA-8995
DRUG: Placebo

Sponsor

Xention Ltd